{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:43:48Z","timestamp":1788965028881,"version":"build-2803163510"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13054-019-2352-6","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T14:04:50Z","timestamp":1550844290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement"],"prefix":"10.1186","volume":"23","author":[{"given":"Marion","family":"Wiegele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6028-1551","authenticated-orcid":false,"given":"Herbert","family":"Sch\u00f6chl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Haushofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ortler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Leitgeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Kwasny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"2352_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00508-013-0456-6","volume":"126","author":"W Mauritz","year":"2014","unstructured":"Mauritz W, Brazinova A, Majdan M, Leitgeb J. Epidemiology of traumatic brain injury in Austria. Wien Klin Wochenschr. 2014;126:42\u201352.","journal-title":"Wien Klin Wochenschr"},{"key":"2352_CR2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00701-015-2512-7","volume":"157","author":"W Peeters","year":"2015","unstructured":"Peeters W, van den Brande R, Polinder S, Brazinova A, Steyerberg EW, Lingsma HF, et al. Epidemiology of traumatic brain injury in Europe. Acta Neurochir. 2015;157:1683\u201396.","journal-title":"Acta Neurochir"},{"key":"2352_CR3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.wneu.2015.02.023","volume":"83","author":"E Herou","year":"2015","unstructured":"Herou E, Romner B, Tomasevic G. Acute traumatic brain injury: mortality in the elderly. World Neurosurg. 2015;83:996\u20131001.","journal-title":"World Neurosurg."},{"key":"2352_CR4","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/S2468-2667(16)30017-2","volume":"1","author":"M Majdan","year":"2016","unstructured":"Majdan M, Plancikova D, Brazinova A, Rusnak M, Nieboer D, Feigin V, et al. Epidemiology of traumatic brain injuries in Europe: a cross-sectional analysis. Lancet Public Health. 2016;1:e76\u201383.","journal-title":"Lancet Public Health"},{"key":"2352_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","volume":"24","author":"JA Frontera","year":"2016","unstructured":"Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, et al. Guideline for reversal of Antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care society and Society of Critical Care Medicine. Neurocrit Care. 2016;24:6\u201346.","journal-title":"Neurocrit Care"},{"key":"2352_CR6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/TA.0000000000001245","volume":"81","author":"JM Feeney","year":"2016","unstructured":"Feeney JM, Santone E, DiFiori M, Kis L, Jayaraman V, Montgomery SC. Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: a TQIP study. J Trauma Acute Care Surg. 2016;81:843\u20138.","journal-title":"J Trauma Acute Care Surg"},{"key":"2352_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13049-018-0487-0","volume":"26","author":"O Prexl","year":"2018","unstructured":"Prexl O, Bruckbauer M, Voelckel W, Grottke O, Ponschab M, Maegele M, et al. The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old. Scand J Trauma Resusc Emerg Med. 2018;26:20.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2352_CR8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/TA.0000000000001414","volume":"82","author":"L Kobayashi","year":"2017","unstructured":"Kobayashi L, Barmparas G, Bosarge P, Brown CV, Bukur M, Carrick MM, et al. Novel oral anticoagulants and trauma: the results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. J Trauma Acute Care Surg. 2017;82:827\u201335.","journal-title":"J Trauma Acute Care Surg"},{"key":"2352_CR9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3171\/jns.2004.100.5.0825","volume":"100","author":"J Ibanez","year":"2004","unstructured":"Ibanez J, Arikan F, Pedraza S, Sanchez E, Poca MA, Rodriguez D, et al. Reliability of clinical guidelines in the detection of patients at risk following mild head injury: results of a prospective study. J Neurosurg. 2004;100:825\u201334.","journal-title":"J Neurosurg"},{"key":"2352_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0735-6757(00)90009-3","volume":"18","author":"GM Vilke","year":"2000","unstructured":"Vilke GM, Chan TC, Guss DA. Use of a complete neurological examination to screen for significant intracranial abnormalities in minor head injury. Am J Emerg Med. 2000;18:159\u201363.","journal-title":"Am J Emerg Med"},{"key":"2352_CR11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1468-1331.2011.03581.x","volume":"19","author":"PE Vos","year":"2012","unstructured":"Vos PE, Alekseenko Y, Battistin L, Ehler E, Gerstenbrand F, Muresanu DF, et al. Mild traumatic brain injury. Eur J Neurol. 2012;19:191\u20138.","journal-title":"Eur J Neurol"},{"key":"2352_CR12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.annemergmed.2008.08.021","volume":"52","author":"AS Jagoda","year":"2008","unstructured":"Jagoda AS, Bazarian JJ, Bruns JJ Jr, Cantrill SV, Gean AD, Howard PK, et al. Clinical policy: neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med. 2008;52:714\u201348.","journal-title":"Ann Emerg Med"},{"key":"2352_CR13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013742","volume":"6","author":"M Kuczawski","year":"2016","unstructured":"Kuczawski M, Stevenson M, Goodacre S, Teare MD, Ramlakhan S, Morris F, et al. Should all anticoagulated patients with head injury receive a CT scan? Decision-analysis modelling of an observational cohort. BMJ Open. 2016;6:e013742.","journal-title":"BMJ Open"},{"key":"2352_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1741-7015-11-50","volume":"11","author":"J Unden","year":"2013","unstructured":"Unden J, Ingebrigtsen T, Romner B, Scandinavian NC. Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med. 2013;11:50.","journal-title":"BMC Med"},{"key":"2352_CR15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002313","volume":"14","author":"WR Mower","year":"2017","unstructured":"Mower WR, Gupta M, Rodriguez R, Hendey GW. Validation of the sensitivity of the National Emergency X-radiography Utilization Study (NEXUS) head computed tomographic (CT) decision instrument for selective imaging of blunt head injury patients: an observational study. PLoS Med. 2017;14:e1002313.","journal-title":"PLoS Med"},{"key":"2352_CR16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1553-2712.2011.01094.x","volume":"18","author":"YS Ro","year":"2011","unstructured":"Ro YS, Shin SD, Holmes JF, Song KJ, Park JO, Cho JS, et al. Comparison of clinical performance of cranial computed tomography rules in patients with minor head injury: a multicenter prospective study. Acad Emerg Med. 2011;18:597\u2013604.","journal-title":"Acad Emerg Med"},{"key":"2352_CR17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(00)04561-X","volume":"357","author":"IG Stiell","year":"2001","unstructured":"Stiell IG, Wells GA, Vandemheen K, Clement C, Lesiuk H, Laupacis A, et al. The Canadian CT Head Rule for patients with minor head injury. Lancet. 2001;357:1391\u20136.","journal-title":"Lancet."},{"key":"2352_CR18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/02688697.2011.650736","volume":"26","author":"JS Batchelor","year":"2012","unstructured":"Batchelor JS, Grayson A. A meta-analysis to determine the effect of anticoagulation on mortality in patients with blunt head trauma. Br J Neurosurg. 2012;26:525\u201330.","journal-title":"Br J Neurosurg"},{"key":"2352_CR19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archsurg.2010.313","volume":"146","author":"LA Dossett","year":"2011","unstructured":"Dossett LA, Riesel JN, Griffin MR, Cotton BA. Prevalence and implications of preinjury warfarin use: an analysis of the National Trauma Databank. Arch Surg. 2011;146:565\u201370.","journal-title":"Arch Surg"},{"key":"2352_CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/TA.0b013e31812e519b","volume":"63","author":"FM Pieracci","year":"2007","unstructured":"Pieracci FM, Eachempati SR, Shou J, Hydo LJ, Barie PS. Use of long-term anticoagulation is associated with traumatic intracranial hemorrhage and subsequent mortality in elderly patients hospitalized after falls: analysis of the New York State Administrative Database. J Trauma. 2007;63:519\u201324.","journal-title":"J Trauma"},{"key":"2352_CR21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/cc11292","volume":"16","author":"C Beynon","year":"2012","unstructured":"Beynon C, Hertle DN, Unterberg AW, Sakowitz OW. Clinical review: traumatic brain injury in patients receiving antiplatelet medication. Crit Care. 2012;16:228.","journal-title":"Crit Care"},{"key":"2352_CR22","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/TA.0b013e3181e5e286","volume":"70","author":"ES Brewer","year":"2011","unstructured":"Brewer ES, Reznikov B, Liberman RF, Baker RA, Rosenblatt MS, David CA, et al. Incidence and predictors of intracranial hemorrhage after minor head trauma in patients taking anticoagulant and antiplatelet medication. J Trauma. 2011;70:E1\u20135.","journal-title":"J Trauma"},{"key":"2352_CR23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/TA.0b013e3181978e7b","volume":"66","author":"WD McMillian","year":"2009","unstructured":"McMillian WD, Rogers FB. Management of prehospital antiplatelet and anticoagulant therapy in traumatic head injury: a review. J Trauma. 2009;66:942\u201350.","journal-title":"J Trauma"},{"key":"2352_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.2015.4393","volume":"34","author":"CL van den Brand","year":"2017","unstructured":"van den Brand CL, Tolido T, Rambach AH, Hunink MG, Patka P, Jellema K. Systematic review and meta-analysis: is pre-injury antiplatelet therapy associated with traumatic intracranial hemorrhage? J Neurotrauma. 2017;34:1\u20137.","journal-title":"J Neurotrauma"},{"key":"2352_CR25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.annemergmed.2011.12.003","volume":"59","author":"VG Menditto","year":"2012","unstructured":"Menditto VG, Lucci M, Polonara S, Pomponio G, Gabrielli A. Management of minor head injury in patients receiving oral anticoagulant therapy: a prospective study of a 24-hour observation protocol. Ann Emerg Med. 2012;59:451\u20135.","journal-title":"Ann Emerg Med"},{"key":"2352_CR26","first-page":"1600","volume":"71","author":"KA Peck","year":"2011","unstructured":"Peck KA, Sise CB, Shackford SR, Sise MJ, Calvo RY, Sack DI, et al. Delayed intracranial hemorrhage after blunt trauma: are patients on preinjury anticoagulants and prescription antiplatelet agents at risk? J Trauma. 2011;71:1600\u20134.","journal-title":"J Trauma"},{"key":"2352_CR27","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/ene.12429","volume":"21","author":"GG Schoonman","year":"2014","unstructured":"Schoonman GG, Bakker DP, Jellema K. Low risk of late intracranial complications in mild traumatic brain injury patients using oral anticoagulation after an initial normal brain computed tomography scan: education instead of hospitalization. Eur J Neurol. 2014;21:1021\u20135.","journal-title":"Eur J Neurol"},{"key":"2352_CR28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7812\/TPP\/15-095","volume":"20","author":"C Swap","year":"2016","unstructured":"Swap C, Sidell M, Ogaz R, Sharp A. Risk of delayed intracerebral hemorrhage in anticoagulated patients after minor head trauma: the role of repeat cranial computed tomography. Perm J. 2016;20:14\u20136.","journal-title":"Perm J"},{"key":"2352_CR29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00415-017-8701-y","volume":"265","author":"MA Verschoof","year":"2018","unstructured":"Verschoof MA, Zuurbier CCM, de Beer F, Coutinho JM, Eggink EA, van Geel BM. Evaluation of the yield of 24-h close observation in patients with mild traumatic brain injury on anticoagulation therapy: a retrospective multicenter study and meta-analysis. J Neurol. 2018;265:315\u201321.","journal-title":"J Neurol"},{"key":"2352_CR30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/TA.0000000000000542","volume":"78","author":"R Grandhi","year":"2015","unstructured":"Grandhi R, Harrison G, Voronovich Z, Bauer J, Chen SH, Nicholas D, et al. Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients. J Trauma Acute Care Surg. 2015;78:614\u201321.","journal-title":"J Trauma Acute Care Surg"},{"key":"2352_CR31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13049-018-0515-0","volume":"26","author":"F Moustafa","year":"2018","unstructured":"Moustafa F, Roubin J, Pereira B, Barres A, Saint-Denis J, Perrier C, et al. Predictive factors of intracranial bleeding in head trauma patients receiving antiplatelet therapy admitted to an emergency department. Scand J Trauma Resusc Emerg Med. 2018;26:50.","journal-title":"Scand J Trauma Resusc Emerg Med."},{"key":"2352_CR32","unstructured":"National Institute for Health and Care Excellence (UK): Head injury: triage, assessment, investigation and early management of head injury in children, young people and adults. NICE Clinical Guidelines, No. 176. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK332976\/ [Accessed November 2018]."},{"key":"2352_CR33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3109\/02699052.2012.667591","volume":"26","author":"J Ding","year":"2012","unstructured":"Ding J, Yuan F, Guo Y, Chen SW, Gao WW, Wang G, et al. A prospective clinical study of routine repeat computed tomography (CT) after traumatic brain injury (TBI). Brain Inj. 2012;26:1211\u20136.","journal-title":"Brain Inj"},{"key":"2352_CR34","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/01.ta.0000224225.54982.90","volume":"61","author":"ZC Sifri","year":"2006","unstructured":"Sifri ZC, Homnick AT, Vaynman A, Lavery R, Liao W, Mohr A, et al. A prospective evaluation of the value of repeat cranial computed tomography in patients with minimal head injury and an intracranial bleed. J Trauma. 2006;61:862\u20137.","journal-title":"J Trauma"},{"key":"2352_CR35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/02688697.2016.1161173","volume":"30","author":"M Kasprowicz","year":"2016","unstructured":"Kasprowicz M, Burzynska M, Melcer T, Kubler A. A comparison of the Full Outline of UnResponsiveness (FOUR) score and Glasgow coma score (GCS) in predictive modelling in traumatic brain injury. Br J Neurosurg. 2016;30:211\u201320.","journal-title":"Br J Neurosurg"},{"key":"2352_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/TA.0b013e318204fdae","volume":"70","author":"V Bansal","year":"2011","unstructured":"Bansal V, Fortlage D, Lee J, Doucet J, Potenza B, Coimbra R. A new clopidogrel (Plavix) point-of-care assay: rapid determination of antiplatelet activity in trauma patients. J Trauma. 2011;70:65\u20139.","journal-title":"J Trauma"},{"key":"2352_CR37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1227\/NEU.0000000000001406","volume":"80","author":"PV Parry","year":"2017","unstructured":"Parry PV, Choi PA, Bauer JS, Panczykowski DM, Puccio AM, Okonkwo DO. Utility of the aspirin and P2Y12 response assays to determine the effect of antiplatelet agents on platelet reactivity in traumatic brain injury. Neurosurgery. 2017;80:92\u20136.","journal-title":"Neurosurgery."},{"key":"2352_CR38","unstructured":"World Health Organization: Requirements for thromboplastins and plasma used to control oral anticoagulant therapy [Annex 3]. In: WHO Expert Committee on Biological Standardization. Thirty third report. Available from: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/39217\/WHO_TRS_687.pdf;jsessionid=84E5161D830A171D83D39B49C3B834BE?sequence=1 [Accessed October 2018]."},{"key":"2352_CR39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/TA.0b013e31812e5216","volume":"63","author":"FM Pieracci","year":"2007","unstructured":"Pieracci FM, Eachempati SR, Shou J, Hydo LJ, Barie PS. Degree of anticoagulation, but not warfarin use itself, predicts adverse outcomes after traumatic brain injury in elderly trauma patients. J Trauma. 2007;63:525\u201330.","journal-title":"J Trauma"},{"key":"2352_CR40","volume":"7","author":"S Mason","year":"2017","unstructured":"Mason S, Kuczawski M, Teare MD, Stevenson M, Goodacre S, Ramlakhan S, et al. AHEAD study: an observational study of the management of anticoagulated patients who suffer head injury. BMJ Open. 2017;7:e014324.","journal-title":"BMJ Open"},{"key":"2352_CR41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3171\/JNS\/2008\/109\/10\/0664","volume":"109","author":"EM Bershad","year":"2008","unstructured":"Bershad EM, Farhadi S, Suri MF, Feen ES, Hernandez OH, Selman WR, et al. Coagulopathy and inhospital deaths in patients with acute subdural hematoma. J Neurosurg. 2008;109:664\u20139.","journal-title":"J Neurosurg"},{"key":"2352_CR42","volume-title":"Neurosurgical emergencies","author":"BS Kim","year":"2008","unstructured":"Kim BS, Jallo J. Intracranial pressure monitoring and management of raised intracranial pressure. In: Loftus CM, editor. Neurosurgical emergencies. New York: American Association of Neurosurgeons; 2008."},{"key":"2352_CR43","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(14)61685-8","volume":"385","author":"JN Goldstein","year":"2015","unstructured":"Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet. 2015;385:2077\u201387.","journal-title":"Lancet."},{"key":"2352_CR44","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","volume":"128","author":"R Sarode","year":"2013","unstructured":"Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation. 2013;128:1234\u201343.","journal-title":"Circulation."},{"key":"2352_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","volume":"15","author":"T Steiner","year":"2016","unstructured":"Steiner T, Poli S, Griebe M, Husing J, Hajda J, Freiberger A, et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol. 2016;15:566\u201373.","journal-title":"Lancet Neurol"},{"key":"2352_CR46","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49:e46\u2013e110.","journal-title":"Stroke."},{"key":"2352_CR47","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/ijs.12295","volume":"9","author":"GJ Hankey","year":"2014","unstructured":"Hankey GJ, Norrving B, Hacke W, Steiner T. Management of acute stroke in patients taking novel oral anticoagulants. Int J Stroke. 2014;9:627\u201332.","journal-title":"Int J Stroke"},{"key":"2352_CR48","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/j.jvir.2008.11.027","volume":"20","author":"PC Malloy","year":"2009","unstructured":"Malloy PC, Grassi CJ, Kundu S, Gervais DA, Miller DL, Osnis RB, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2009;20:S240\u20139.","journal-title":"J Vasc Interv Radiol"},{"key":"2352_CR49","volume-title":"Das Gerinnungskompendium","author":"S Alban","year":"2013","unstructured":"Alban S. Monitoring der Antikoagulanzien. In: Barthels M, Lavis TN, editors. Das Gerinnungskompendium. Italy: Georg Thieme Verlag; 2013."},{"issue":"Suppl 1","key":"2352_CR50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jth.12227","volume":"11","author":"T Baglin","year":"2013","unstructured":"Baglin T. The role of the laboratory in treatment with new oral anticoagulants. J Thromb Haemost. 2013;11(Suppl 1):122\u20138.","journal-title":"J Thromb Haemost"},{"key":"2352_CR51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-0035-1569734","volume":"4","author":"C Hart","year":"2016","unstructured":"Hart C, Spannagl M, Heimerl S. Gerinnungsmonitoring der neuen, nicht Vitamin K abh\u00e4ngigen oralen Antikoagulanzien. Interventionelle Radiologie Scan. 2016;4:53\u201368.","journal-title":"Interventionelle Radiologie Scan"},{"key":"2352_CR52","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF): R\u00fcckenmarksnahe Regionalan\u00e4sthesien und Thrombembolieprophylaxe\/ antithrombotische Medikation. Available from: https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/001-005l_S1_R%C3%BCckenmarksnahe_Regionalan%C3%A4sthesie_Thromboembolieprophylaxe_2015-01.pdf [Accessed October 2018]."},{"key":"2352_CR53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MBC.0b013e32834f1b0c","volume":"23","author":"J Stangier","year":"2012","unstructured":"Stangier J, Feuring M. Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran. Blood Coagul Fibrinolysis. 2012;23:138\u201343.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2352_CR54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jth.13227","volume":"14","author":"JH Levy","year":"2016","unstructured":"Levy JH, Ageno W, Chan NC, Crowther M, Verhamme P, Weitz JI, et al. When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14:623\u20137.","journal-title":"J Thromb Haemost"},{"key":"2352_CR55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11239-015-1229-z","volume":"41","author":"J Kepplinger","year":"2016","unstructured":"Kepplinger J, Prakapenia A, Barlinn K, Siegert G, Gehrisch S, Zerna C, et al. Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol. J Thromb Thrombolysis. 2016;41:293\u2013300.","journal-title":"J Thromb Thrombolysis"},{"key":"2352_CR56","unstructured":"Steiner T. Neue direkte orale Antikoagulanzien: Was ist im Notfall zu beachten. Dtsch Arztebl. 2012;109:A-1928 \/ B-570 \/ C-542."},{"key":"2352_CR57","unstructured":"Studt J-D. Gerinnungstests und Messparameter f\u00fcr die neuen Antikoagulanzien. Universum InnereMedizin. 2013;09\u20132013:[Angiologie]."},{"key":"2352_CR58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1160\/TH11-06-0391","volume":"107","author":"MM Samama","year":"2012","unstructured":"Samama MM, Contant G, Spiro TE, Perzborn E, Guinet C, Gourmelin Y, et al. Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls. Thromb Haemost. 2012;107:379\u201387.","journal-title":"Thromb Haemost"},{"key":"2352_CR59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/neu.2011.2122","volume":"29","author":"D Kurland","year":"2012","unstructured":"Kurland D, Hong C, Aarabi B, Gerzanich V, Simard JM. Hemorrhagic progression of a contusion after traumatic brain injury: a review. J Neurotrauma. 2012;29:19\u201331.","journal-title":"J Neurotrauma"},{"key":"2352_CR60","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/TA.0b013e3182aafcf0","volume":"76","author":"B Joseph","year":"2014","unstructured":"Joseph B, Pandit V, Aziz H, Kulvatunyou N, Hashmi A, Tang A, et al. Clinical outcomes in traumatic brain injury patients on preinjury clopidogrel: a prospective analysis. J Trauma Acute Care Surg. 2014;76:817\u201320.","journal-title":"J Trauma Acute Care Surg"},{"key":"2352_CR61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12873-016-0094-1","volume":"16","author":"S Narum","year":"2016","unstructured":"Narum S, Brors O, Stokland O, Kringen MK. Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective cohort analysis from a level 1 trauma centre. BMC Emerg Med. 2016;16:29.","journal-title":"BMC Emerg Med"},{"key":"2352_CR62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198301063080102","volume":"308","author":"PM Mannucci","year":"1983","unstructured":"Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med. 1983;308:8\u201312.","journal-title":"N Engl J Med"},{"key":"2352_CR63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1460408616669745","volume":"19","author":"JL Mappus","year":"2016","unstructured":"Mappus JL, Fellows SE, Anand S, Gandhi MA. The use of desmopressin acetate in patients presenting with intracranial hemorrhage: a review. Trauma. 2016;19:3\u201310.","journal-title":"Trauma."},{"key":"2352_CR64","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/STROKEAHA.114.006061","volume":"45","author":"AM Naidech","year":"2014","unstructured":"Naidech AM, Maas MB, Levasseur-Franklin KE, Liotta EM, Guth JC, Berman M, et al. Desmopressin improves platelet activity in acute intracerebral hemorrhage. Stroke. 2014;45:2451\u20133.","journal-title":"Stroke."},{"key":"2352_CR65","doi-asserted-by":"crossref","first-page":"298767","DOI":"10.1155\/2014\/298767","volume":"2014","author":"T Kapapa","year":"2014","unstructured":"Kapapa T, Rohrer S, Struve S, Petscher M, Konig R, Wirtz CR, et al. Desmopressin acetate in intracranial haemorrhage. Neurol Res Int. 2014;2014:298767.","journal-title":"Neurol Res Int"},{"key":"2352_CR66","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1089\/neu.2014.3728","volume":"32","author":"DY Kim","year":"2015","unstructured":"Kim DY, O'Leary M, Nguyen A, Kaji A, Bricker S, Neville A, et al. The effect of platelet and desmopressin administration on early radiographic progression of traumatic intracranial hemorrhage. J Neurotrauma. 2015;32:1815\u201321.","journal-title":"J Neurotrauma"},{"key":"2352_CR67","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13054-016-1265-x","volume":"20","author":"R Rossaint","year":"2016","unstructured":"Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100.","journal-title":"Crit Care"},{"key":"2352_CR68","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jemermed.2007.12.024","volume":"39","author":"T Singleton","year":"2010","unstructured":"Singleton T, Kruse-Jarres R, Leissinger C. Emergency department care for patients with hemophilia and von Willebrand disease. J Emerg Med. 2010;39:158\u201365.","journal-title":"J Emerg Med"},{"key":"2352_CR69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/TA.0b013e31818b2483","volume":"67","author":"H Schochl","year":"2009","unstructured":"Schochl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67:125\u201331.","journal-title":"J Trauma"},{"key":"2352_CR70","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/TA.0b013e318156ee4c","volume":"63","author":"MJ Cohen","year":"2007","unstructured":"Cohen MJ, Brohi K, Ganter MT, Manley GT, Mackersie RC, Pittet JF. Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway. J Trauma. 2007;63:1254\u201361.","journal-title":"J Trauma"},{"key":"2352_CR71","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1474-4422(17)30197-7","volume":"16","author":"M Maegele","year":"2017","unstructured":"Maegele M, Schochl H, Menovsky T, Marechal H, Marklund N, Buki A, et al. Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management. Lancet Neurol. 2017;16:630\u201347.","journal-title":"Lancet Neurol"},{"key":"2352_CR72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ienj.2014.03.004","volume":"23","author":"E Cole","year":"2015","unstructured":"Cole E, Davenport R. Early tranexamic acid use in trauma haemorrhage: why do we give it and which patients benefit most? Int Emerg Nurs. 2015;23:38\u201341.","journal-title":"Int Emerg Nurs"},{"key":"2352_CR73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archsurg.2011.287","volume":"147","author":"JJ Morrison","year":"2012","unstructured":"Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012;147:113\u20139.","journal-title":"Arch Surg"},{"key":"2352_CR74","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/jamasurg.2013.764","volume":"148","author":"JJ Morrison","year":"2013","unstructured":"Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. JAMA Surg. 2013;148:218\u201325.","journal-title":"JAMA Surg"},{"key":"2352_CR75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)61479-1","volume":"376","author":"H Shakur","year":"2010","unstructured":"Crash-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23\u201332.","journal-title":"Lancet"},{"key":"2352_CR76","doi-asserted-by":"crossref","first-page":"d3795","DOI":"10.1136\/bmj.d3795","volume":"343","author":"Crash-2 Collaborators (Intracranial Bleeding Study)","year":"2011","unstructured":"Crash-2 Collaborators (Intracranial Bleeding Study). Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ. 2011;343:d3795.","journal-title":"BMJ"},{"key":"2352_CR77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-227X-13-20","volume":"13","author":"S Yutthakasemsunt","year":"2013","unstructured":"Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, Thinkamrop B, Phuenpathom N, Lumbiganon P. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial. BMC Emerg Med. 2013;13:20.","journal-title":"BMC Emerg Med."},{"key":"2352_CR78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cjtee.2016.02.005","volume":"20","author":"A Jokar","year":"2017","unstructured":"Jokar A, Ahmadi K, Salehi T, Sharif-Alhoseini M, Rahimi-Movaghar V. The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial. Chin J Traumatol. 2017;20:49\u201351.","journal-title":"Chin J Traumatol"},{"key":"2352_CR79","doi-asserted-by":"crossref","unstructured":"Chakroun-Walha O, Samet A, Jerbi M, Nasri A, Talbi A, Kanoun H, et al. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients. Eur J Trauma Emerg Surg. 2018:[Epub ahead of print].","DOI":"10.1007\/s00068-018-0974-z"},{"key":"2352_CR80","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/TA.0b013e3182a96591","volume":"75","author":"B Joseph","year":"2013","unstructured":"Joseph B, Pandit V, Sadoun M, Larkins CG, Kulvatunyou N, Tang A, et al. A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage. J Trauma Acute Care Surg. 2013;75:990\u20134.","journal-title":"J Trauma Acute Care Surg"},{"key":"2352_CR81","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","volume":"387","author":"MI Baharoglu","year":"2016","unstructured":"Baharoglu MI, Cordonnier C, Al-Shahi Salman R, de Gans K, Koopman MM, Brand A, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387:2605\u201313.","journal-title":"Lancet."},{"key":"2352_CR82","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/02699052.2018.1425804","volume":"32","author":"JL Holzmacher","year":"2018","unstructured":"Holzmacher JL, Reynolds C, Patel M, Maluso P, Holland S, Gamsky N, et al. Platelet transfusion does not improve outcomes in patients with brain injury on antiplatelet therapy. Brain Inj. 2018;32:325\u201330.","journal-title":"Brain Inj"},{"key":"2352_CR83","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/000313480907501115","volume":"75","author":"DM Downey","year":"2009","unstructured":"Downey DM, Monson B, Butler KL, Fortuna GR Jr, Saxe JM, Dolan JP, et al. Does platelet administration affect mortality in elderly head-injured patients taking antiplatelet medications? Am Surg. 2009;75:1100\u20133.","journal-title":"Am Surg"},{"key":"2352_CR84","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1179\/174313209X459129","volume":"32","author":"AF Ducruet","year":"2010","unstructured":"Ducruet AF, Hickman ZL, Zacharia BE, Grobelny BT, DeRosa PA, Landes E, et al. Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage. Neurol Res. 2010;32:706\u201310.","journal-title":"Neurol Res"},{"key":"2352_CR85","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jss.2014.08.016","volume":"193","author":"A Briggs","year":"2015","unstructured":"Briggs A, Gates JD, Kaufman RM, Calahan C, Gormley WB, Havens JM. Platelet dysfunction and platelet transfusion in traumatic brain injury. J Surg Res. 2015;193:802\u20136.","journal-title":"J Surg Res"},{"key":"2352_CR86","first-page":"137","volume":"90","author":"MA Crowther","year":"2005","unstructured":"Crowther MA, Ageno W, Schnurr T, Manfredi E, Kinnon K, Garcia D, et al. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin. Haematologica. 2005;90:137\u20139.","journal-title":"Haematologica."},{"key":"2352_CR87","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/trf.14166","volume":"57","author":"T Sahai","year":"2017","unstructured":"Sahai T, Tavares MF, Sweeney JD. Rapid response to intravenous vitamin K may obviate the need to transfuse prothrombin complex concentrates. Transfusion. 2017;57:1885\u201390.","journal-title":"Transfusion."},{"key":"2352_CR88","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5694\/mja13.10685","volume":"200","author":"HA Tran","year":"2014","unstructured":"Tran HA, Chunilal SD, Tran H. An update of consensus guidelines for warfarin reversal. Med J Aust. 2014;200:82.","journal-title":"Med J Aust"},{"key":"2352_CR89","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0037-1613443","volume":"89","author":"M Yasaka","year":"2003","unstructured":"Yasaka M, Minematsu K, Naritomi H, Sakata T, Yamaguchi T. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost. 2003;89:278\u201383.","journal-title":"Thromb Haemost"},{"key":"2352_CR90","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","volume":"46","author":"JC Hemphill 3rd","year":"2015","unstructured":"Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015;46:2032\u201360.","journal-title":"Stroke."},{"key":"2352_CR91","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2008.02904.x","volume":"6","author":"I Pabinger","year":"2008","unstructured":"Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H, et al. Prothrombin complex concentrate (Beriplex P\/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost. 2008;6:622\u201331.","journal-title":"J Thromb Haemost"},{"key":"2352_CR92","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1537-2995.2008.02080.x","volume":"49","author":"L Holland","year":"2009","unstructured":"Holland L, Warkentin TE, Refaai M, Crowther MA, Johnston MA, Sarode R. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion. 2009;49:1171\u20137.","journal-title":"Transfusion."},{"key":"2352_CR93","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.amjsurg.2016.02.007","volume":"211","author":"DT Martin","year":"2016","unstructured":"Martin DT, Barton CA, Dodgion C, Schreiber M. Emergent reversal of vitamin K antagonists: addressing all the factors. Am J Surg. 2016;211:919\u201325.","journal-title":"Am J Surg"},{"key":"2352_CR94","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/phar.1384","volume":"34","author":"TK Huynh","year":"2014","unstructured":"Huynh TK, Costello JL, Rebuck JA. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy. Pharmacotherapy. 2014;34:260\u20134.","journal-title":"Pharmacotherapy."},{"key":"2352_CR95","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1160\/TH13-07-0536","volume":"111","author":"A Majeed","year":"2014","unstructured":"Majeed A, Meijer K, Larrazabal R, Arnberg F, Luijckx GJ, Roberts RS, et al. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate. Thromb Haemost. 2014;111:233\u20139.","journal-title":"Thromb Haemost"},{"key":"2352_CR96","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jocn.2014.05.001","volume":"21","author":"V Yanamadala","year":"2014","unstructured":"Yanamadala V, Walcott BP, Fecci PE, Rozman P, Kumar JI, Nahed BV, et al. Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage. J Clin Neurosci. 2014;21:1881\u20134.","journal-title":"J Clin Neurosci"},{"key":"2352_CR97","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/000313481408000419","volume":"80","author":"M Edavettal","year":"2014","unstructured":"Edavettal M, Rogers A, Rogers F, Horst M, Leng W. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients. Am Surg. 2014;80:372\u20136.","journal-title":"Am Surg"},{"key":"2352_CR98","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.wneu.2010.06.030","volume":"74","author":"NA Pinner","year":"2010","unstructured":"Pinner NA, Hurdle AC, Oliphant C, Reaves A, Lobo B, Sills A. Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII. World Neurosurg. 2010;74:631\u20135.","journal-title":"World Neurosurg."},{"key":"2352_CR99","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.wneu.2012.12.002","volume":"81","author":"CH Woo","year":"2014","unstructured":"Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, et al. Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. World Neurosurg. 2014;81:110\u20135.","journal-title":"World Neurosurg."},{"key":"2352_CR100","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1182\/blood-2017-05-782060","volume":"130","author":"A Majeed","year":"2017","unstructured":"Majeed A, Agren A, Holmstrom M, Bruzelius M, Chaireti R, Odeberg J, et al. Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study. Blood. 2017;130:1706\u201312.","journal-title":"Blood."},{"key":"2352_CR101","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12878-015-0039-z","volume":"15","author":"M Sholzberg","year":"2015","unstructured":"Sholzberg M, Pavenski K, Shehata N, Cserti-Gazdewich C, Lin Y. Bleeding complications from the direct oral anticoagulants. BMC Hematol. 2015;15:18.","journal-title":"BMC Hematol"},{"key":"2352_CR102","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.thromres.2015.07.001","volume":"136","author":"C Beynon","year":"2015","unstructured":"Beynon C, Sakowitz OW, Storzinger D, Orakcioglu B, Radbruch A, Potzy A, et al. Intracranial haemorrhage in patients treated with direct oral anticoagulants. Thromb Res. 2015;136:560\u20135.","journal-title":"Thromb Res"},{"key":"2352_CR103","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00068-017-0772-z","volume":"43","author":"JF Barletta","year":"2017","unstructured":"Barletta JF, Hall S, Sucher JF, Dzandu JK, Haley M, Mangram AJ. The impact of pre-injury direct oral anticoagulants compared to warfarin in geriatric G-60 trauma patients. Eur J Trauma Emerg Surg. 2017;43:445\u20139.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"2352_CR104","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","volume":"377","author":"CV Pollack Jr","year":"2017","unstructured":"Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, et al. Idarucizumab for dabigatran reversal - full cohort analysis. N Engl J Med. 2017;377:431\u201341.","journal-title":"N Engl J Med"},{"key":"2352_CR105","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ajem.2017.03.072","volume":"35","author":"A Riccardi","year":"2017","unstructured":"Riccardi A, Spinola B, Minuto P, Ghinatti M, Guiddo G, Malerba M, et al. Intracranial complications after minor head injury (MHI) in patients taking vitamin K antagonists (VKA) or direct oral anticoagulants (DOACs). Am J Emerg Med. 2017;35:1317\u20139.","journal-title":"Am J Emerg Med"},{"key":"2352_CR106","doi-asserted-by":"crossref","unstructured":"Carnevale JA, Segar DJ, Powers AY, Shah M, Doberstein C, Drapcho B, et al. Blossoming contusions: identifying factors contributing to the expansion of traumatic intracerebral hemorrhage. J Neurosurg. 2018;129:1305\u201316.","DOI":"10.3171\/2017.7.JNS17988"},{"key":"2352_CR107","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.amjsurg.2006.12.004","volume":"193","author":"K Denson","year":"2007","unstructured":"Denson K, Morgan D, Cunningham R, Nigliazzo A, Brackett D, Lane M, et al. Incidence of venous thromboembolism in patients with traumatic brain injury. Am J Surg. 2007;193:380\u20133 discussion 3-4.","journal-title":"Am J Surg"},{"key":"2352_CR108","first-page":"10","volume":"14","author":"AJ Praeger","year":"2012","unstructured":"Praeger AJ, Westbrook AJ, Nichol AD, Wijemunige R, Davies AR, Lyon SM, et al. Deep vein thrombosis and pulmonary embolus in patients with traumatic brain injury: a prospective observational study. Crit Care Resusc. 2012;14:10\u20133.","journal-title":"Crit Care Resusc"},{"key":"2352_CR109","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/TA.0000000000000294","volume":"77","author":"JM Van Gent","year":"2014","unstructured":"Van Gent JM, Bandle J, Calvo RY, Zander AL, Olson EJ, Shackford SR, et al. Isolated traumatic brain injury and venous thromboembolism. J Trauma Acute Care Surg. 2014;77:238\u201342.","journal-title":"J Trauma Acute Care Surg"},{"key":"2352_CR110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TA.0b013e318031b5f5","volume":"62","author":"AB Nathens","year":"2007","unstructured":"Nathens AB, McMurray MK, Cuschieri J, Durr EA, Moore EE, Bankey PE, et al. The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma. 2007;62:557\u201362.","journal-title":"J Trauma"},{"key":"2352_CR111","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurg. 2017;80:6\u201315.","journal-title":"Neurosurg"},{"key":"2352_CR112","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1017\/cjn.2017.275","volume":"45","author":"J Margolick","year":"2018","unstructured":"Margolick J, Dandurand C, Duncan K, Chen W, Evans DC, Sekhon MS, et al. A systematic review of the risks and benefits of venous thromboembolism prophylaxis in traumatic brain injury. Can J Neurol Sci. 2018;45:432\u201344.","journal-title":"Can J Neurol Sci"},{"key":"2352_CR113","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/TA.0b013e31818a0e74","volume":"65","author":"SH Norwood","year":"2008","unstructured":"Norwood SH, Berne JD, Rowe SA, Villarreal DH, Ledlie JT. Early venous thromboembolism prophylaxis with enoxaparin in patients with blunt traumatic brain injury. J Trauma. 2008;65:1021\u20136.","journal-title":"J Trauma"},{"key":"2352_CR114","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jamcollsurg.2016.06.382","volume":"223","author":"JP Byrne","year":"2016","unstructured":"Byrne JP, Mason SA, Gomez D, Hoeft C, Subacius H, Xiong W, et al. Timing of pharmacologic venous thromboembolism prophylaxis in severe traumatic brain injury: a propensity-matched cohort study. J Am Coll Surg. 2016;223:621\u201331 e5.","journal-title":"J Am Coll Surg"},{"key":"2352_CR115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/neuros\/nyx164","volume":"81","author":"FA Frisoli","year":"2017","unstructured":"Frisoli FA, Shinseki M, Nwabuobi L, Zeng XL, Adrados M, Kanter C, et al. Early venous thromboembolism chemoprophylaxis after traumatic intracranial hemorrhage. Neurosurgery. 2017;81:1016\u201320.","journal-title":"Neurosurgery."},{"key":"2352_CR116","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/TA.0000000000001321","volume":"82","author":"JP Byrne","year":"2017","unstructured":"Byrne JP, Geerts W, Mason SA, Gomez D, Hoeft C, Murphy R, et al. Effectiveness of low-molecular-weight heparin versus unfractionated heparin to prevent pulmonary embolism following major trauma: a propensity-matched analysis. J Trauma Acute Care Surg. 2017;82:252\u201362.","journal-title":"J Trauma Acute Care Surg"},{"key":"2352_CR117","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2009-07-231506","volume":"115","author":"N Lubenow","year":"2010","unstructured":"Lubenow N, Hinz P, Thomaschewski S, Lietz T, Vogler M, Ladwig A, et al. The severity of trauma determines the immune response to PF4\/heparin and the frequency of heparin-induced thrombocytopenia. Blood. 2010;115:1797\u2013803.","journal-title":"Blood."},{"key":"2352_CR118","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/TA.0b013e31822734c9","volume":"71","author":"CT Minshall","year":"2011","unstructured":"Minshall CT, Eriksson EA, Leon SM, Doben AR, McKinzie BP, Fakhry SM. Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score >2. J Trauma. 2011;71:396\u20139.","journal-title":"J Trauma"},{"key":"2352_CR119","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/JBM.S125209","volume":"8","author":"H Wong","year":"2017","unstructured":"Wong H, Lovett N, Curry N, Shah K, Stanworth SJ. Antithrombotics in trauma: management strategies in the older patients. J Blood Med. 2017;8:165\u201374.","journal-title":"J Blood Med"},{"key":"2352_CR120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.wneu.2011.03.034","volume":"76","author":"GW Hawryluk","year":"2011","unstructured":"Hawryluk GW, Furlan JC, Austin JW, Fehlings MG. Survey of neurosurgical management of central nervous system hemorrhage in patients receiving anticoagulation therapy: current practice is highly variable and may be suboptimal. World Neurosurg. 2011;76:299\u2013303.","journal-title":"World Neurosurg."},{"key":"2352_CR121","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamainternmed.2014.2534","volume":"174","author":"JS Albrecht","year":"2014","unstructured":"Albrecht JS, Liu X, Baumgarten M, Langenberg P, Rattinger GB, Smith GS, et al. Benefits and risks of anticoagulation resumption following traumatic brain injury. JAMA Intern Med. 2014;174:1244\u201351.","journal-title":"JAMA Intern Med"},{"key":"2352_CR122","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jss.2016.06.042","volume":"205","author":"K Matsushima","year":"2016","unstructured":"Matsushima K, Inaba K, Cho J, Mohammed H, Herr K, Leichtle S, et al. Therapeutic anticoagulation in patients with traumatic brain injury. J Surg Res. 2016;205:186\u201391.","journal-title":"J Surg Res"},{"key":"2352_CR123","volume":"10","author":"Y Puckett","year":"2018","unstructured":"Puckett Y, Zhang K, Blasingame J, Lorenzana J, Parameswaran S, Brooks M, Facs SE, et al. Safest Time to Resume Oral Anticoagulation in Patients with Traumatic Brain Injury. Cureus. 2018;10:e2920.","journal-title":"Cureus"},{"key":"2352_CR124","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.wneu.2016.01.063","volume":"89","author":"T Tykocki","year":"2016","unstructured":"Tykocki T, Guzek K. Anticoagulation therapy in traumatic brain injury. World Neurosurg. 2016;89:497\u2013504.","journal-title":"World Neurosurg"},{"key":"2352_CR125","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.593087","volume":"41","author":"A Majeed","year":"2010","unstructured":"Majeed A, Kim YK, Roberts RS, Holmstrom M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010;41:2860\u20136.","journal-title":"Stroke."},{"key":"2352_CR126","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2010.03882.x","volume":"8","author":"GW Hawryluk","year":"2010","unstructured":"Hawryluk GW, Austin JW, Furlan JC, Lee JB, O'Kelly C, Fehlings MG. Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost. 2010;8:1500\u20138.","journal-title":"J Thromb Haemost"},{"key":"2352_CR127","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","volume":"48","author":"J Pennlert","year":"2017","unstructured":"Pennlert J, Overholser R, Asplund K, Carlberg B, Van Rompaye B, Wiklund PG, et al. Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation. Stroke. 2017;48:314\u201320.","journal-title":"Stroke."},{"key":"2352_CR128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s13063-015-0898-4","volume":"16","author":"KM van Nieuwenhuizen","year":"2015","unstructured":"van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, et al. Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial. Trials. 2015;16:393.","journal-title":"Trials."},{"key":"2352_CR129","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1160\/TH14-04-0305","volume":"113","author":"JD Douketis","year":"2015","unstructured":"Douketis JD, Healey JS, Brueckmann M, Eikelboom JW, Ezekowitz MD, Fraessdorf M, et al. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost. 2015;113:625\u201332.","journal-title":"Thromb Haemost"},{"key":"2352_CR130","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00701-009-0419-x","volume":"151","author":"T Niemi","year":"2009","unstructured":"Niemi T, Silvasti-Lundell M, Armstrong E, Hernesniemi J. The Janus face of thromboprophylaxis in patients with high risk for both thrombosis and bleeding during intracranial surgery: report of five exemplary cases. Acta Neurochir. 2009;151:1289\u201394.","journal-title":"Acta Neurochir"},{"key":"2352_CR131","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1160\/TH13-07-0552","volume":"110","author":"S Apostolakis","year":"2013","unstructured":"Apostolakis S, Lane DA, Buller H, Lip GY. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Thromb Haemost. 2013;110:1074\u20139.","journal-title":"Thromb Haemost"},{"key":"2352_CR132","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955\u201362.","journal-title":"Lancet."},{"key":"2352_CR133","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/ijs.12309","volume":"9","author":"T Steiner","year":"2014","unstructured":"Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European stroke organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke. 2014;9:840\u201355.","journal-title":"Int J Stroke"},{"key":"2352_CR134","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00508-013-0390-7","volume":"125","author":"H Watzke","year":"2013","unstructured":"Watzke H, Metzler H, Weltermann A, Marschang P, Brodmann M, Lang W, et al. Periprocedual management of vitamin K antagonist's with low molecular weight heparins during invasive procedures\u2014consensus of experts. Wien Klin Wochenschr. 2013;125:412\u201320.","journal-title":"Wien Klin Wochenschr"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2352-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-019-2352-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2352-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T11:40:44Z","timestamp":1662982844000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2352-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2352"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2352-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"24 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MW reports speaker fees and travel reimbursement from CSL Behring. HS reports speaker fees and study grants from CSL Behring, Werfen\/TEM International, B\u00f6hringer Ingelheim RCV GmbH & Co KG Austria, and Haemonetics Corporation. AH reports personal fees (consulting services and\/or speaker honoraria) from Boehringer Ingelheim RCV GmbH & Co KG Austria, Novo Nordisc Pharma GmbH Austria, and Daiichi-Sankyo Austria GmbH. MO reports speakers\u2019 honoraria and symposium support from Baxalta \u00d6sterreich GmbH. RB reports personal fees (consulting services and speaker honoraria) from Boehringer Ingelheim RCV GmbH & Co KG Austria. CA reports personal fees (consulting services and\/or speaker honoraria) from Bayer Austria, Boehringer Ingelheim RCV GmbH & Co KG Austria, Daiichi-Sankyo Austria GmbH, and Shire Austria GmbH. ES reports speaker fees from Baxalta \u00d6sterreich GmbH, Boehringer Ingelheim RCV GmbH & Co KG Austria, Daiichi-Sankyo Austria GmbH, and Shire Austria GmbH. The other authors declare that they do not have competing interests. The authors did not receive any financial compensation related to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"62"}}